Compare Dolby Laboratories, Inc. (DLB) vs iShares Core MSCI Emerging Markets ETF (IEMG) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Dolby Laboratories, Inc. vs iShares Core MSCI Emerging Markets ETF — how do they compare? Dolby Laboratories, Inc. trades at $58.74 (market cap $5.47B), while iShares Core MSCI Emerging Markets ETF trades at $81.4 (market cap $162.00B). The key difference: iShares Core MSCI Emerging Markets ETF is far larger — about 29.6× Dolby Laboratories, Inc.'s market cap, and Dolby Laboratories, Inc. pays a 2.46% dividend while iShares Core MSCI Emerging Markets ETF pays none. Which is the better fit depends on your goals — on Pluang, investors hold Dolby Laboratories, Inc. for 98 Days and iShares Core MSCI Emerging Markets ETF for 57 Days on average.
| DLB | IEMG | |
|---|---|---|
Market Cap | $5.47B | $162.00B |
Volume | 1,058,284 | 13,446,151 |
Sector | Technology | Broad Market / Factor |
52-Week High | $69.58 | $86.00 |
52-Week Low | $48.51 | $64.22 |
Typical Hold Time | 98 Days | 57 Days |
Enterprise Value | $4.85B | — |
Dividend Yield | 2.46% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Dolby Laboratories (DLB) trades at $58.45, showing modest daily gains of 0.17%. The stock faces bearish technical signals with resistance at $59 and support at $58. Fundamentally, DLB maintains strong profitability with 87.61% gross margins and has beaten earnings estimates in three consecutive quarters. Recent developments include expanded partnerships with Meta and leadership transition to new CEO Marc Whitten.
DLB presents a mixed outlook with analyst consensus pointing to significant upside (target $90.33) despite near-term execution risks. The company's strong cash position and expanding digital content partnerships provide growth catalysts, though licensing volatility and competitive pressures remain key challenges for investors.
IEMG is trading at $80.50, down 1.88% for the day amid bearish technical signals. The ETF shows strong emerging markets exposure with 39% technology sector weighting and has delivered significant outperformance versus peers over the past year. Recent news highlights IEMG's role in portfolio diversification strategies and its competitive position against other emerging markets ETFs.
The outlook remains cautious given bearish technical indicators, though emerging markets flows are at record levels. Key opportunities include continued EM outperformance and technology exposure, while risks involve concentration concerns and higher volatility compared to developed market alternatives. The 0.09% expense ratio provides cost efficiency for long-term EM exposure.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About Dolby Laboratories, Inc.
Dolby Laboratories Inc develops audio and surround sound for cinema, broadcast, home audio systems, in-car entertainment systems, DVD players, games, televisions, and personal computers. The company generates three fourths of its revenue from licensing its technology to consumer electronics manufacturers around the world. The rest of revenue comes from equipment sales to professional producers and audio engineering services.
Read more on DLB →About iShares Core MSCI Emerging Markets ETF
IEMG tracks the MSCI Emerging Markets Investable Market Index, providing broad exposure to large, mid, and small-cap stocks across over 20 emerging market countries. It is designed as a low-cost core holding for investors seeking diversified growth from economies outside of developed markets.
Read more on IEMG →
